IP Library Granted Patent US 10,378,020
Granted Patent B2
US 10,378,020 · App. 16/110,728 · Granted Aug 13, 2019

High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems

Inventors: Richard T. Sayre (Los Alamos, NM); Elton Carvalho Gonçalves (Los Alamos, NM); Tawanda Zidenga (White Rock, NM)
Assignee: TRAIT BIOSCIENCES, INC.
C12N15/8243C12N9/0065C12Y111/01006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,378,020
App. No.
16/110,728
Granted
Aug 13, 2019
Kind
B2
Abstract

The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Claims (41)

1. A method for the production of water-soluble cannabinoids in a Cannabis cell cytosol:

genetically modifying a cultured Cannabis cell to transiently express:

i. a nucleotide sequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removed;

ii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity toward a cannabinoid to generate a hydroxylated cannabinoid or a cannabinoid carboxylic acid;

iii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from nicotinamide adenine dinucleotide phosphate (NADPH) to the cytochrome P450; and

iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids.

2. The method of claim 1 wherein said at least one cannabinoid synthase having its trichome targeting signal disrupted or removed is selected from the group consisting of: the nucleotide sequence according to SEQ ID NO. 22, and the nucleotide sequence according to SEQ ID NO. 46.

3. The method of claim 1 wherein said at least one cannabinoid synthase having its trichome targeting signal disrupted or removed is selected from the group consisting of: a CBG synthase; a THCA synthase, a CBDA synthase, a CBCA synthase.

4. The method of claim 1 wherein said nucleotide sequence encoding the heterologous cytochrome P450 comprises the nucleotide sequence of SEQ ID NO. 1.

5. The method of claim 1 wherein said nucleotide sequence encoding the heterologous P450 oxidoreductase comprises the nucleotide sequence of SEQ ID NO. 3.

6. The method of claim 1 wherein said nucleotide sequence encoding the heterologous glycosyltransferase is selected from the group consisting of: the nucleotide sequence of SEQ ID NO. 7, the nucleotide sequence of SEQ ID NO. 27, the nucleotide sequence of SEQ ID NO. 29, the nucleotide sequence of SEQ ID NO. 31, the nucleotide sequence of SEQ ID NO. 37, and a homologous nucleotide sequence to SEQ ID NOs. 27, 29, 31 and 37 from Nicotiana benthamiana encoding a heterologous glycosyltransferase having glycosylation activity towards one or more cannabinoids.

7. The method of claim 1 further comprising the step of transiently expressing a nucleotide sequence encoding an endogenous myb transcription factor from Cannabis wherein the endogenous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathway.

8. The method of claim 7 wherein said endogenous myb transcription factor from Cannabis is selected from the group consisting of: the nucleotide sequence of SEQ ID NO. 11, and the amino acid sequence of SEQ ID NO. 12.

9. The method of claim 1 further comprising the step of transiently expressing a nucleotide sequence encoding a heterologous myb transcription factor wherein the heterologous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathway.

10. The method of claim 9 wherein said heterologous myb transcription factor is selected from the group consisting of: the amino acid sequence of SEQ ID NO. 43, the amino acid sequence of SEQ ID NO. 44, and the amino acid sequence of SEQ ID NO. 45.

11. The method of claim 1 further comprising the step of transiently expressing a nucleotide sequence encoding a heterologous catalase having reduction activity towards hydrogen peroxide generated by cannabinoid biosynthesis.

12. The method of claim 11 wherein said nucleotide sequence encoding a heterologous catalase is selected from the group consisting of: the nucleotide sequence of SEQ ID NO. 13, and the nucleotide sequence of SEQ ID NO. 15.

13. A method for producing water-soluble cannabinoids in the cytosol of a plant comprising the steps:

genetically modifying at least one Cannabis plant through Agrobacterium -mediated transformation to transiently express:

i. a nucleotide sequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removed;

ii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid to generate a hydroxylated cannabinoid, or a cannabinoid carboxylic acid;

iii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450; and

iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids.

14. The method of claim 13 further comprising the step of transiently expressing a nucleotide sequence encoding an endogenous or heterologous myb transcription factor wherein said heterologous or heterologous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathway.

15. The method of claim 13 further comprising the step of transiently expressing a nucleotide sequence encoding a heterologous catalase having reduction activity towards hydrogen peroxide generated by cannabinoid biosynthesis.

16. A method for producing water-soluble cannabinoids in a Cannabis plant cell comprising the steps:

genetically modifying at least one Cannabis plant cell through Agrobacterium -mediated transformation to transiently express:

i. a nucleotide sequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removed;

ii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid to generate a hydroxylated cannabinoid, or a cannabinoid carboxylic acid;

iii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450; and

iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids;

v. a nucleotide sequence encoding an endogenous or heterologous myb transcription factor wherein said heterologous or heterologous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathway; and

vi. a nucleotide sequence encoding a heterologous catalase having reduction activity towards hydrogen peroxide generated by cannabinoid biosynthesis.

17. A method for producing water-soluble cannabinoids in a Cannabis cell comprising the steps:

genetically modifying at least one Cannabis cell to transiently express:

i. a nucleotide sequence encoding at least one cannabinoid synthase having its trichome targeting signal disrupted or removed;

ii. a nucleotide sequence encoding a heterologous cytochrome P450 having hydroxylation or oxidation activity towards a cannabinoid to generate a hydroxylated cannabinoid, or a cannabinoid carboxylic acid;

iii. a nucleotide sequence encoding a heterologous P450 oxidoreductase that facilitates electron transfer from NADPH to the cytochrome P450; and

iv. a nucleotide sequence encoding a heterologous glycosyltransferase having glycosylation activity towards said cannabinoids, said hydroxylated cannabinoids, and said cannabinoid carboxylic acids;

v. a nucleotide sequence encoding an endogenous or heterologous myb transcription factor wherein said heterologous or heterologous myb transcription factor increases cannabinoid production by enhancing metabolite flux through the cannabinoid biosynthetic pathway; and

vi. a nucleotide sequence encoding a heterologous catalase having reduction activity towards hydrogen peroxide generated by cannabinoid biosynthesis.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2021
From: GOTHAM GREEN ADMIN 1, LLC
To: TRAIT BIOSCIENCES INC., TRAIT NM INC., TRAIT BIOSCIENCES (CANADA) INC., AND TWIGG PHARMA LTD.
Reel/Frame 055705/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: CARVALHO GONÇALVES, ELTON, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: ZIDENGA, TAWANDA, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2020
From: SAYRE, RICHARD T., DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054623/0738 →
SECURITY INTEREST Recorded Jun 26, 2020
From: TRAIT BIOSCIENCES INC.; TRAIT NM INC.; TRAIT BIOSCIENCES (CANADA) INC.; TWIGG PHARMA LTD.
To: GOTHAM GREEN ADMIN 1, LLC
Reel/Frame 053057/0852 →
Continuity (5)
Continuation In Part PCTUS2018024409 · Mar 26, 2018
Provisional Application 62476080 · Mar 24, 2017
Provisional Application 62588662 · Nov 20, 2017
Provisional Application 62621166 · Jan 24, 2018
Related Publication 20190085347A1 · Mar 21, 2019
Cited By (1)
US 12,460,185